Listed Funds Trust Dividend Performers ETF (BATS: IPDP)

Latest news for Listed Funds Trust Dividend Performers ETF (BATS:IPDP)

Industrials

Healthcare

Technology

Financial Services

Consumer Cyclical

Basic Materials

Innovative Portfolios

The investment seeks to provide income; the secondary objective is capital appreciation. The fund’s investment strategy is twofold: (1) investing in dividend paying U.S. equity securities, and (2) credit spread options on an S&P 500 ETF or Index. It may also invest in equity real estate investment trusts (“REITs”). A credit spread is an options strategy that involves the purchase of one option and a sale of another option in the same class and with the same expiration but different strike prices.

Hni Corp

Cencora Inc

Abm Industries Inc

Mckesson Corp.

Unitedhealth Group Inc.

Apple Inc.

Brown & Brown Inc

Motorola Solutions Inc

Home Depot, Inc.

Johnson & Johnson

Dividend Performers ETF

The SPY Slides Ahead Of Big-Tech Earnings Week: This ETF Offers A Diversified Approach To Large-Cap Dividend-Paying Stocks

Long Ideas

Sector ETFs

Short Ideas

Specialty ETFs

New ETFs

Technicals

Trading Ideas

ETFs

Listed Funds Trust Dividend Performers ETF

IPDP

The SPDR S&amp;P 500 (NYSE: SPY) was dropping about 0.6% on Monday ahead of a big week of earnings, where Microsoft Corporation, Meta Platforms, Alphabet, Coca-Cola and multiple other mega-cap companies 

A new player in the AI arena, DeepSeek, has unveiled an open-source language model, R1, that experts say is a game-changer in efficiency, raising questions about the <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43244653/bitcoin-ethereum-solana-crash-heres-why-chinas-low-cost-ai-model-deepseek-may-be-to-blame">future of AI development.</a>
<h2 class="wp-block-heading">The DeepSeek Effect</h2>
Developed for under $6 million, DeepSeek&#8217;s R1 has not only outperformed established competitors in several tests but has also called into question the established big-spending approach prevalent in Silicon Valley. 
This development has triggered a mix of optimism about democratized AI and fears of an AI stock bubble bursting, sending ripples throughout financial markets.
&#8220;Another DeepSeek is hiding in plain sight,&#8221; said Roi Ginat, CEO of Endless AI, a multimodal AI company, highlighting DeepSeek's influence in making impactful AI with limited resources. 
Ginat&#8217;s own company, EndlessAI, has been working on efficient video processing, echoing DeepSeek's stand to using LLMs in practical, cost-effective ways. 
Ginat told Benzinga that EndlessAI provides the tools to make existing models work smarter by using proprietary video transfer optimization which enables massive cost reduction for video processing, adding that this is complementary, not competitive, with what DeepSeek is doing.
Speaking with Benzinga, Satya Nitta, CEO of Emergence AI, an AI orchestration company, echoed the sentiment, calling DeepSeek R1 a &#8220;meaningful advance in broadening access to AI reasoning.&#8221; 
Nitta emphasized the importance of open-source solutions that are not only trusted but also scalable and adaptable to evolving needs.
Matthew Putman, CEO of Nanotronics, an industrial AI company, told Benzinga that DeepSeek&#8217;s achievement demonstrates that &#8220;it is possible to do more with less,&#8221; suggesting that resource constraints may fuel innovation. 
Putman sees these developments as essential for broader adoption of AI for industries beyond just text generation, stressing it's critical for advancing semiconductor production, which makes AI technology possible.
Mitesh Agrawal, CEO of Positron, an AI hardware company, pointed to DeepSeek&#8217;s success as evidence that &#8220;inference-time compute is the new scaling factor&#8221; in AI development, delivering real results with optimized systems. 
Agrawal told Benzinga that performance per dollar and performance per watt are critical to make the best AI models accessible.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43356514/helix-debuts-ai-index-perpetual-market">Helix Debuts AI Index Perpetual Market, Bridging Crypto And Traditional Equities On-Chain</a>
<h2 class="wp-block-heading">Is DeepSeek A Cause For Concern?</h2>
However, concerns also accompany this disruptive innovation.
Speaking with Benzinga, Pukar Hamal, CEO of SecurityPal, an AI-enhanced security review company, warned about the security and regulatory implications of an "open-source" model with unknown alignment. 
Hamal highlighted the &#8220;gas law&#8221; of computing, whereby cheaper compute expands markets, but also stressed the need for guardrails to protect the public and maintain compliance.
These concerns translated into market jitters on the day DeepSeek news first broke.
The Nasdaq Composite dropped 2.7% on Monday, the S&amp;P 500 slid 1.6% and the Dow Jones Industrial Average dipped 0.1% following the DeepSeek announcement.
The announcement of a new low-cost, high-performance open source AI model that competes with existing proprietary AI systems also drove volatility in the cryptocurrency market. 
Crypto markets also took a hit, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) falling 5.5% and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) dropping 7% on Monday before recovering.
Other major altcoins also experienced significant losses, as traders grappled with the potential implications of DeepSeek&#8217;s emergence.
On Monday, altcoins like Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), BNB (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>), Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) were down 11%, 3.5%, 9% and 8.5%, respectively.
<h2 class="wp-block-heading">What&#8217;s Next For DeepSeek</h2>
DeepSeek's disruptive impact is already rippling through financial markets. 
The sharp declines in AI-related stocks and cryptocurrencies suggest that investors are reassessing the sustainability of current AI valuations. 
Analysts warn that DeepSeek's ability to deliver high-performance AI at a fraction of traditional costs may force industry leaders to rethink their strategies.
Moreover, experts believe DeepSeek's approach could reshape the $25 billion computer vision market and redefine the scalability of AI applications. 
As companies continue to push the boundaries of multimodal AI, the industry appears poised for a shift toward leaner, more efficient AI models that can thrive outside the confines of billion-dollar research labs.
In the face of this transformation, the question remains: will legacy AI firms adapt to the new paradigm, or will DeepSeek's breakthrough mark the beginning of a broader industry upheaval?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43351797/grayscale-seeks-sec-approval-to-convert-xrp-trust-into-exchange-traded-fund">Grayscale Seeks SEC Approval To Convert XRP Trust Into Exchange-Traded Fund</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$ADA

$BNB

$BTC

$DOGE

$ETH

$SOL

Experts Say DeepSeek Proves High-Performance AI Possible Without Silicon Valley's Spending

Guidance

ABBV

AbbVie Sees FY25 Adj. EPS $12.12-$12.32 vs $10.08 Est.; Reaffirms Long-Term Revenue Growth Outlook of High Single-Digit CAGR Through 2029

YMAB

Y-mAbs Therapeutics Says It Will Present Preclinical And Translational Pharmacokinetics Data Of GD2-SADA In A Poster At Society Of Nuclear Medicine & Molecular Imaging Mid-winter And American College Of Nuclear Medicine Annual Meeting

Hitachi (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HTHIY#OTC">HTHIY</a>) reported its Q3 earnings results on Friday, January 31, 2025 at 07:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Hitachi missed estimated earnings by -9.0%, reporting an EPS of $0.4 versus an estimate of $0.44.
Revenue was up $903.00 million from the same period last year.
<h3>Historical Earnings Summary</h3>
In the previous quarter, the company missed on EPS by $0.07, resulting in a 5.0% increase change in the share price the following day.
Here's a look at Hitachi's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.41</td>
<td>0.05</td>
<td>0.33</td>
<td>0.34</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.34</td>
<td>0.49</td>
<td>1.02</td>
<td>0.64</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>15.82B</td>
<td>12.27B</td>
<td>15.53B</td>
<td>13.49B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>15.68B</td>
<td>14.19B</td>
<td>18.68B</td>
<td>15.28B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Hitachi management provided guidance for FY 2024, expecting earnings between $0.91 and $0.91 per share.
To track all earnings releases for Hitachi <a href="https://www.benzinga.com/quote/HTHIY/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

HTHIY

Earnings Summary: Hitachi Q3

AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) reported quarterly earnings of $2.16 per share which beat the analyst consensus estimate of $2.11 by 2.37 percent. This is a 22.58 percent decrease over earnings of $2.79 per share from the same period last year. The company reported quarterly sales of $15.102 billion which beat the analyst consensus estimate of $14.827 billion by 1.85 percent. This is a 5.60 percent increase over sales of $14.301 billion the same period last year.

Earnings Beats

AbbVie Q4 2024 Adj. EPS $2.16 Beats $2.11 Estimate, Sales $15.102B Beat $14.827B Estimate

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Lineage Cell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LCTX#AMEX">LCTX</a>) with a Buy and maintains $9 price target.

Price Target

Reiteration

Analyst Ratings

LCTX

HC Wainwright & Co. Reiterates Buy on Lineage Cell Therapeutics, Maintains $9 Price Target

First BanCorp. Reveals Strategic Reorganization Aligned With Corporate Succession Plan Aimed At Improving Operational Efficiency, Enhancing Customer Experience, And Driving Business Transformation To Align Resources For Growth

HC Wainwright &amp; Co. analyst Edward White reiterates Valneva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>) with a Buy and maintains $18 price target.

VALN

HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $18 Price Target

Samsung Electronics Co (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) <a target="_blank" href="https://www.benzinga.com/topic/samsung" rel="noreferrer noopener">reported fourth-quarter revenue</a> growth of 12% year-on-year to 75.8 trillion Korean won ($52.2 billion).
Operating profit declined by 30% Q/Q to 6.5 trillion Korean won due to soft market conditions, especially for IT products, and higher R&amp;D expenditures.
The DS Division (encompassing Memory and S.LSI / Foundry) posted 30.1 trillion Korean won in revenue (versus 21.7 trillion Korean won Y/Y) backed by a higher blended DRAM average selling price (ASP) due to the increased sales of high-bandwidth memory (HBM) and high-density <a target="_blank" href="https://www.samsung.com/global/ir/financial-information/earnings-release/" rel="noreferrer noopener">DDR5 for servers</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43165472/samsung-taps-google-ai-qualcomm-tech-for-galaxy-s25-to-rival-apples-iphone" rel="noreferrer noopener">Samsung Taps Google AI, Qualcomm Tech for Galaxy S25 to Rival Apple&#8217;s iPhone</a>
The division reported 2.9 trillion Korean won in operating profit (versus a loss of (2.2) trillion Korean won Y/Y).
Samsung Display Corp Division, posted 8.1 trillion Korean won in revenue (versus 9.7 trillion Korean won Y/Y). The division reported 0.9 trillion Korean won in operating profit (versus 2.0 trillion Korean won Y/Y) due to sluggish smartphone demand and rising competition for the mobile display business.
The Mobile eXperience (MX) and Networks businesses posted 25.8 trillion Korean won in revenue (versus 25.0 Korean won Y/Y). The division reported 2.1 trillion Korean won in operating profit (versus 2.7 trillion Korean won Y/Y).
The quarterly capex was 17.8 trillion Korean won, with 16 trillion Korean won allocated to the DS Division and 1 trillion Korean won to SDC.
While overall earnings improvement may be limited in the first quarter of 2025 due to weakness in the semiconductors business, the company aims to pursue growth through increased sales of smartphones with differentiated AI experiences and premium products in the Device eXperience (DX) Division.
For 2025, the company plans to enhance technological and product advantages in AI, meet future demand for high-value-added products, and drive sales growth in premium segments.
Samsung, in a preliminary earnings report, flagged sluggish demand for conventional chips used in personal computers and mobile phones weighed on its memory business, with earnings also dented by rising R&amp;D costs and early investments in expanding advanced-chip processing capability, the Wall Street Journal <a target="_blank" href="https://www.wsj.com/business/earnings/samsungs-net-profit-beats-consensus-but-chip-woes-weigh-cad40447?mod=tech_lead_pos1" rel="noreferrer noopener">reports</a>.
SK Hynix has left Samsung behind in HBM, Eric Ross of Cascend Securities, <a target="_blank" href="https://www.cnbc.com/2025/01/31/samsung-fourth-quarter-profit-falls-short-of-estimates-as-ai-demand-remains-strong.html" rel="noreferrer noopener">told</a> CNBC. Micron Technology, Inc also gained ground, Ross told. PC and smartphone DRAM markets are under price pressure, he added.
Nabila Popal of IDC told CNBC that Samsung&#8217;s share of the premium market has inched closer to market leader Apple Inc thanks to the former&#8217;s Galaxy S24 series featuring Galaxy AI.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/media/25/01/43352019/amazon-cuts-more-jobs-in-cost-saving-push-report" target="_blank" rel="noreferrer noopener">Amazon Cuts More Jobs in Cost-Saving Push: Report</a></li>
</ul>
Image via Shutterstock.

Equities

Media

SSNLF

Samsung Q4 Earnings: 12% Revenue Growth, Closes Gap With Apple In Premium Phones, Eyes AI-Powered Growth In 2025

NLSP

NLS Pharmaceutics And Kadimastem Says Shareholders Approved Their Merger, Bringing Companies One Step Closer To Creating A Combined Nasdaq-traded Biotechnology Company With Portfolio Of Advanced Therapies For Neurodegenerative Diseases And Diabetes

WIIM

KLAC

KLA Corp shares are trading higher following better-than-expected Q2 financial results.

Needham analyst Laura Martin reiterates Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) with a Buy and maintains $260 price target.

AAPL

Needham Reiterates Buy on Apple, Maintains $260 Price Target

TEAM

Atlassian shares are trading higher after the company reported better-than-expected Q2 financial results.

Shares of Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) rose by 4.02% in premarket on Friday following better-than-expected first-quarter revenue and earnings per share. CEO Tim Cook described Q1 as their &#8220;best quarter ever&#8221;. However, iPhone and China sales fell below expectations for the given quarter.
What Happened: Apple stock closed 0.74% lower on Thursday after which the company reported its first-quarter earnings.
While its revenue reached $124.3 billion as compared to the $124.13 billion <a href="https://www.benzinga.com/quote/AAPL/earnings">expected</a> by <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, the adjusted EPS also surpassed expectations at $2.40 as compared to the <a href="https://www.benzinga.com/quote/AAPL/earnings">estimates</a> of $2.36 per share.
However, the iPhone sales slipped to $69.14 billion, versus $69.7 billion in the same quarter last year.
With a good Q1, the company beat eight consecutive quarters of expectations, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The iPhone maker&#8217;s success was fueled by growth in its services sector and strong performance in international markets. Services revenue, which includes offerings like Apple Music and iCloud, climbed to $26.34 billion, up significantly from $23.12 billion last year.
See Also: <a href="https://www.benzinga.com/news/earnings/25/01/43355688/apple-q1-earnings-revenue-beat-eps-beat-iphone-sales-slip-installed-base-climbs-to-all-time-high-our-best-quarter-ever">Apple Q1 Earnings: Revenue Beat, EPS Beat, iPhone Sales Slip, Installed Base Climbs To All-Time High — &#8216;Our Best Quarter Ever&#8217;</a>
Geographically, Apple saw robust sales across various regions. The Americas contributed $52.65 billion, while Europe generated $33.86 billion. Japan brought in $8.99 billion, and the rest of the Asia-Pacific region contributed $10.29 billion. Greater China sales were at $18.51 billion, but Wall Street expected $21.5 billion from China.
Product revenue totaled $97.96 billion, a slight increase from $96.46 billion the previous year. Mac sales rose to $8.99 billion from $7.78 billion, and iPad sales also increased to $8.09 billion from $7.02 billion. Sales of Wearables, Home and Accessories, however, saw a slight decline, reaching $11.75 billion compared to $11.95 billion last year.
See Also: <a href="https://www.benzinga.com/government/regulations/25/01/43377987/after-imposing-tariffs-on-canada-donald-trump-threatens-100-levy-on-brics-for-move-against">After Imposing Tariffs On Canada, Donald Trump Threatens 100% Levy On BRICS For Move Against Dollar: &#8216;How Will US Manage Production From Slippers To Ships?,&#8217; Asks Expert</a>
Why It Matters: Despite fluctuations in specific product categories, Apple highlighted a significant milestone. Its active installed base of devices reached an all-time high across all product lines and geographic segments.
&#8220;Today Apple is reporting our best quarter ever, with revenue of $124.3 billion, up 4% from a year ago," said Cook, Apple's CEO. Cook also emphasized the company's focus on innovation, stating, "Through the power of Apple silicon, we're unlocking new possibilities for our users with Apple Intelligence, which makes apps and experiences even better and more personal. And we're excited that Apple Intelligence will be available in even more languages this April."
Price Action: Shares rose over 4% to $247.14, during the publication of this article, whereas the exchange-traded fund tracking Nasdaq 100, Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.85% to $527.50.
Apple has gained 28.84% over the last year and 6.98% in the last six months.
The average price target among 30 analysts <a href="https://www.benzinga.com/quote/AAPL/analyst-ratings">tracked by Benzinga</a> is $246.79 with a &#8216;buy&#8217; rating. The estimates range from $188 to $325 apiece. Recent ratings from Morgan Stanley, Evercore ISI Group, and BofA Securities suggest a $266.67 target, implying a potential upside of 8.45%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/AAPL/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="381" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31071704/Apple-ANR-1024x381.png" alt="" class="wp-image-760024" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31071704/Apple-ANR-1024x381.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31071704/Apple-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31071704/Apple-ANR-768x286.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31071704/Apple-ANR.png 1066w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43378308/tokenization-for-protection-mastercard-shields-4-billion-monthly-transactions-in-2024-fortifying-data-against-breaches">Mastercard&#8217;s Secret Weapon Against Fraud? A 40x Growth In This Security Tech</a></li>
</ul>
Image via Shutterstock

Market Summary

Broad U.S. Equity ETFs

Futures

Pre-Market Outlook

Markets

General

Apple Shares Jump Over 4% In Pre-Market After Tim Cook Calls Q1 'Best Quarter Ever' For iPhone Maker

INTC

Intel shares are trading higher following better-than-expected Q4 financial results.

Janus Henderson Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $0.94 by 13.83 percent. This is a 30.49 percent increase over earnings of $0.82 per share from the same period last year. The company reported quarterly sales of $708.30 million which beat the analyst consensus estimate of $679.15 million by 4.29 percent. This is a 24.59 percent increase over sales of $568.50 million the same period last year.

Janus Henderson Group plc Ordinary Shares

Janus Henderson Group Q4 Adj EPS $1.07 Beats $0.94 Estimate, Sales $708.30M Beat $679.15M Estimate

Needham analyst Mike Matson reiterates ResMed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) from Hold to Hold.

Needham Reiterates Hold on ResMedto Hold

Northland Capital Markets analyst Tim Savageaux reiterates Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) with a Outperform and raises the price target from $13 to $14.

VIAV

Northland Capital Markets Reiterates Outperform on Viavi Solutions, Raises Price Target to $14

Northland Capital Markets analyst Gus Richard maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Outperform and lowers the price target from $154 to $140.

Northland Capital Markets Maintains Outperform on Teradyne, Lowers Price Target to $140

Bristol Myers Squibb Says Committee For Medicinal Products For Human Use Of European Medicines Agency Ecommended Approval Of  Opdivo(nivolumab) Plus Yervoy(ipilimumab For First-line Treatment Of Adult Patients With Unresectable Or Advanced Hepatocellular Carcinoma, Based On Results From The Phase 3 CheckMate -9Dw Trial

Click To Tune In Here...&nbsp;https://www.youtube.com/watch?v=yFfR-NSqnng

Events

COPJ

HRTS

IPPP

JEPY

LITP

PHYS

PSLV

QQQY

RSHO

URNJ

Benzinga's 'ETFs Unlocked' Conference Has Begun

The SPDR S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was dropping about 0.6% on Monday ahead of a big week of earnings, where Microsoft Corporation, Meta Platforms, Alphabet, Coca-Cola and multiple other mega-cap companies <a href="https://www.benzinga.com/markets/asia/23/10/35358005/investor-risk-sentiment-wavers-amid-war-interest-rate-concerns-tesla-earnings-disappoint-the-week-in">are set to report</a>.

On Wednesday, Tesla set the tone, kicking off the quarterly earnings season <a href="https://www.benzinga.com/news/earnings/23/10/35318136/tesla-q3-earnings-highlights-revenue-miss-eps-miss-cybertruck-launch-set-for-november-and-more">with a double miss</a>, which caused the stock to fall almost 10% the following day and continue to slide on Friday and Monday, dragging the general market lower.

On Friday, the SPY closed under the 200-day simple moving average (SMA) on higher-than-average volume, throwing the stock market into a possible bear cycle.

Whether or not the bear cycle will come into full effect or if the companies reporting earnings this week can cause the SPY to reverse course remains to be seen. Traders who are bullish on the stock market and see the value of diversification, particularly those who choose to capture gains through dividends, can take a position in <a href="https://innovativeportfolios.com/ipdp-dividend-performers-etf/">Innovative Portfolios&rsquo;</a> Dividend Performers ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPDP#NYSE">IPDP</a>).

Must Read:&nbsp;<a href="https://www.benzinga.com/etfs/23/10/35345713/warren-buffetts-billion-dollar-dividend-duo-apple-and-coca-cola-account-for-over-1-6-billion-a-year">Warren Buffett&#39;s Billion-Dollar Dividend Duo: Apple and Coca-Cola Account For Over $1.6 Billion A Year In Income For Berkshire Hathaway</a>

IPDP is an actively managed ETF that seeks diversified cash flow through dividends, capital appreciation, and options premiums. The fund primarily holds shares of large-cap U.S.-based companies with a history of raising dividends over time.

Want direct analysis? Find me in the BZ Pro lounge! <a href="https://benzinga.grsm.io/1ih7p9hphj9p">Click here for a free trial</a>.

The IPDP Chart: IPDP&nbsp;has followed the general market lower since Wednesday but on declining volume, indicating the bears are losing interest. On Friday, the ETF fell under the 200-day SMA and on Monday, IPDP gapped down to start the trading session but was holding steady at the opening price.

<ul>
	<li>The fund negated its uptrend on Wednesday by forming a lower low, which was under the Oct. 13 low of $15.40 but hasn&rsquo;t yet confirmed a new downtrend with the formation of a lower high. IPDP is likely to bounce up to at least form a lower high over the next few days because its relative strength index is measuring in at about 35%, putting it near oversold territory.</li>
	<li>On the monthly chart, IPDP is trading in an uptrend and looking to form an inverted hammer candlestick to close out October. If the candle is recognized, IPDP may see bullish price action in November, possibly making the fund a good longer-term hold.</li>
	<li>On the daily chart, IDPD has resistance above at $14.88 and at $15.56 and support below at $14.26 and at $13.88.</li>
</ul>

<img alt="screenshot_64.png" src="https://www.benzinga.com/files/u278075/screenshot_64.png" style="height:427px; width:760px" />Read Next:&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35362006/is-it-time-to-bet-on-small-caps-analysts-share-insights-on-the-valuation-gap-versus">Is It Time to Bet on Small Caps? Analysts Share Insights On The Valuation Gap Versus Large Caps</a>

Comments

Listed Funds Trust Dividend Performers ETF

News

Latest news for Listed Funds Trust Dividend Performers ETF (BATS:IPDP)

Thursday, November 30, 2023

Monday, October 23, 2023

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga